Brief: Biosergen Q2 EBITDA Loss Narrows To SEK 5.7 Million
30/08/2024 07:18
Aug 30 (Reuters) - Biosergen AB BIOSGN.ST :
* Q2 EBITDA LOSS SEK 5.7 MILLION VERSUS LOSS NOK 8 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr3JRSr4
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million